Ioflupane I-123 has 19 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Amoxapine, Amphetamine, Armodafinil. Patients taking Ioflupane I-123 should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 19
- Moderate
- 19
Moderate (19)
- Ioflupane I-123 + Amoxapine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Amphetamine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Armodafinil— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Benztropine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Bupropion— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Buspirone— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Citalopram— May increase or decrease ioflupane binding to dopamine transporter and may interfere with imaging results.
- Ioflupane I-123 + Cocaine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Desvenlafaxine— Cases of altered DATSCAN uptake that impacted image interpretation have been reported.
- Ioflupane I-123 + Mazindol— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Methamphetamine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Methylphenidate— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Modafinil— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Paroxetine— May increase or decrease ioflupane binding to dopamine transporter and may interfere with imaging results.
- Ioflupane I-123 + Phentermine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Phenylpropanolamine— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Selegiline— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Sertraline— Binds to dopamine transporter with high affinity and may interfere with Ioflupane I-123 imaging results.
- Ioflupane I-123 + Venlafaxine— Cases of altered DATSCAN uptake that impacted image interpretation have been reported.